Jundishapur Journal of Microbiology

Published by: Kowsar

Phenotypic Detection of Efflux Mechanism in Panaminoglycoside Resistant Acinetobacter baumannii from Egyptian Clinical Isolates

Nesrein T. Moustafa 1 , * , Ahmed O. El-gendy 2 , Amal E. Saafan 3 and Wael M. Tawakkol 4
Authors Information
1 Microbiology and Immunology Department, Misr University for Science and Technology, 6th of October City, Egypt
2 Microbiology and Immunology Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
3 Microbiology Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
4 Microbiology Department, Faculty of Pharmacy, Misr University for Science and Technology, 6th of October City, Egypt
Article information
  • Jundishapur Journal of Microbiology: October 2018, 11 (10); e69541
  • Published Online: September 9, 2018
  • Article Type: Research Article
  • Received: April 18, 2018
  • Revised: August 18, 2018
  • Accepted: August 23, 2018
  • DOI: 10.5812/jjm.69541

To Cite: Moustafa N T, El-gendy A O , Saafan A E, Tawakkol W M. Phenotypic Detection of Efflux Mechanism in Panaminoglycoside Resistant Acinetobacter baumannii from Egyptian Clinical Isolates, Jundishapur J Microbiol. 2018 ; 11(10):e69541. doi: 10.5812/jjm.69541.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Denton M, Wilcox MH, Parnell P, Green D, Keer V, Hawkey PM, et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect. 2004;56(2):106-10. doi: 10.1016/j.jhin.2003.10.017. [PubMed: 15019221].
  • 2. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36(7):1938-41. [PubMed: 9650940]. [PubMed Central: PMC104956].
  • 3. Bureau-Chalot F, Drieux L, Pierrat-Solans C, Forte D, de Champs C, Bajolet O. Blood pressure cuffs as potential reservoirs of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii. J Hosp Infect. 2004;58(1):91-2. doi: 10.1016/j.jhin.2004.05.013. [PubMed: 15350724].
  • 4. Hrenovic J, Durn G, Goic-Barisic I, Kovacic A. Occurrence of an environmental Acinetobacter baumannii strain similar to a clinical isolate in paleosol from Croatia. Appl Environ Microbiol. 2014;80(9):2860-6. doi: 10.1128/AEM.00312-14. [PubMed: 24584245]. [PubMed Central: PMC3993276].
  • 5. Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, et al. Acinetobacter baumannii: An emerging multidrug-resistant pathogen in critical care. Crit Care Nurse. 2008;28(1):15-25. quiz 26. [PubMed: 18238934].
  • 6. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006;50(12):4114-23. doi: 10.1128/AAC.00778-06. [PubMed: 17000742]. [PubMed Central: PMC1694013].
  • 7. Cherkaoui A, Emonet S, Renzi G, Schrenzel J. Characteristics of multidrug-resistant Acinetobacter baumannii strains isolated in Geneva during colonization or infection. Ann Clin Microbiol Antimicrob. 2015;14:42. doi: 10.1186/s12941-015-0103-3. [PubMed: 26361784]. [PubMed Central: PMC4567826].
  • 8. Peralta G, Sanchez MB, Garrido JC, De Benito I, Cano ME, Martinez-Martinez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother. 2007;60(4):855-63. doi: 10.1093/jac/dkm279. [PubMed: 17644532].
  • 9. Gaynes R, Edwards JR, National Nosocomial Infections Surveillance S. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41(6):848-54. doi: 10.1086/432803. [PubMed: 16107985].
  • 10. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999;43(4):727-37. [PubMed: 10103173]. [PubMed Central: PMC89199].
  • 11. Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev. 2003;16(3):430-50. [PubMed: 12857776]. [PubMed Central: PMC164221].
  • 12. Jones MB, Nierman WC, Shan Y, Frank BC, Spoering A, Ling L, et al. Reducing the Bottleneck in Discovery of Novel Antibiotics. Microb Ecol. 2017;73(3):658-67. doi: 10.1007/s00248-016-0889-3. [PubMed: 27896376].
  • 13. Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, et al. Structure of the AcrAB-TolC multidrug efflux pump. Nature. 2014;509(7501):512-5. doi: 10.1038/nature13205. [PubMed: 24747401]. [PubMed Central: PMC4361902].
  • 14. Li XZ, Plesiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337-418. doi: 10.1128/CMR.00117-14. [PubMed: 25788514]. [PubMed Central: PMC4402952].
  • 15. Lee Y, Yum JH, Kim CK, Yong D, Jeon EH, Jeong SH, et al. Role of OXA-23 and AdeABC efflux pump for acquiring carbapenem resistance in an Acinetobacter baumannii strain carrying the blaOXA-66 gene. Ann Clin Lab Sci. 2010;40(1):43-8. [PubMed: 20124329].
  • 16. Coyne S, Courvalin P, Perichon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother. 2011;55(3):947-53. doi: 10.1128/AAC.01388-10. [PubMed: 21173183]. [PubMed Central: PMC3067115].
  • 17. Bijari A, Azimi L, Fallah F, Ardebili A, Lari ER, Lari AR. Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran. Infect Disord Drug Targets. 2016;16(3):172-7. [PubMed: 27572250].
  • 18. Hamouda A, Amyes SG. Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin. J Antimicrob Chemother. 2004;54(3):695-6. doi: 10.1093/jac/dkh368. [PubMed: 15282231].
  • 19. Zechini B, Versace I. Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov. 2009;4(1):37-50. [PubMed: 19149695].
  • 20. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006;19(2):382-402. doi: 10.1128/CMR.19.2.382-402.2006. [PubMed: 16614254]. [PubMed Central: PMC1471989].
  • 21. Ardebili A, Talebi M, Azimi L, Rastegar Lari A. Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates. Jundishapur J Microbiol. 2014;7(1). e8691. doi: 10.5812/jjm.8691. [PubMed: 25147654]. [PubMed Central: PMC4138672].
  • 22. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. [PubMed: 21793988].
  • 23. Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis. 2007;45(1):88-94. doi: 10.1086/518605. [PubMed: 17554708].
  • 24. Greub G, Schrenzel J. [The new face of diagnostic microbiology]. Rev Med Suisse. 2014;10(450):2123-4. [PubMed: 25549371].
  • 25. Omar BA, Atif HA, Mogahid ME. Comparison of three DNA extraction methods for polymerase chain reaction (PCR) analysis of bacterial genomic DNA. African J Microbiol Res. 2014;8(6):598-602. doi: 10.5897/ajmr2013.6459.
  • 26. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974-6. doi: 10.1128/JCM.01021-06. [PubMed: 16891520]. [PubMed Central: PMC1594603].
  • 27. National Nosocomial Infection Surveillance System. National nosocomial infections surveillance (NNIS) system report, data summary from january 1992 through june 2004, issued october 2004. Am J Infect Control. 2004;32(8):470-85. doi: 10.1016/j.ajic.2004.10.001.
  • 28. Wayne PA. Performance standards or antimicrobial susceptibility testing; twenty informational supplement. Clin Lab Stand Inst. 2010:CLSI document M100-S19.
  • 29. Andrews JM, Basc Working Party on Susceptibility Testing . BSAC standardized disc susceptibility testing method (version 5). J Antimicrob Chemother. 2006;58(3):511-29. doi: 10.1093/jac/dkl277. [PubMed: 16840429].
  • 30. Wayne PA. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Clin Lab Stand Inst. 2013:CLSI document M100-S23.
  • 31. Pumbwe L, Glass D, Wexler HM. Efflux pump overexpression in multiple-antibiotic-resistant mutants of Bacteroides fragilis. Antimicrob Agents Chemother. 2006;50(9):3150-3. doi: 10.1128/AAC.00141-06. [PubMed: 16940115]. [PubMed Central: PMC1563565].
  • 32. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939-51. doi: 10.1038/nrmicro1789. [PubMed: 18007677].
  • 33. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471-84. doi: 10.1128/AAC.01464-06. [PubMed: 17646423]. [PubMed Central: PMC2043292].
  • 34. Eijkelkamp BA, Stroeher UH, Hassan KA, Paulsen IT, Brown MH. Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii. BMC Genomics. 2014;15:1020. doi: 10.1186/1471-2164-15-1020. [PubMed: 25422040]. [PubMed Central: PMC4256060].
  • 35. Cho YJ, Moon DC, Jin JS, Choi CH, Lee YC, Lee JC. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn Microbiol Infect Dis. 2009;64(2):185-90. doi: 10.1016/j.diagmicrobio.2009.02.010. [PubMed: 19361944].
  • 36. Aitta AA, El Said M, El Dabaa E, El Salam MA, Mahdy HM. Detection of plasmid-mediated 16S rRNA methylase conferring high-level resistance to aminoglycosides in gram negative bacilli from Egypt. Life Sci J. 2012;9(4).
  • 37. Ndegwa DW, Budambula NLM, Kariuki S, Revathi G, Kiiru JN. Aminoglycoside modifying enzymes detected in strains of escherichia, klebsiella, pseudomonas and acinetobacter implicated in invasive infections in Nairobi, Kenya. Scientific Conference Proceedings. 2012.
  • 38. Aghazadeh M, Rezaee MA, Nahaei MR, Mahdian R, Pajand O, Saffari F, et al. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist. 2013;19(4):282-8. doi: 10.1089/mdr.2012.0223. [PubMed: 23577624].
  • 39. Nasrolahei M, Zahedi B, Bahador A, Saghi H, Kholdi S, Jalalvand N, et al. Distribution of bla(OXA-23), ISAba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran. Ann Clin Microbiol Antimicrob. 2014;13:38. doi: 10.1186/s12941-014-0038-0. [PubMed: 25252850]. [PubMed Central: PMC4353670].
  • 40. Hasani A, Sheikhalizadeh V, Ahangarzadeh Rezaee M, Rahmati-Yamchi M, Hasani A, Ghotaslou R, et al. Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran. Microb Drug Resist. 2016;22(5):347-53. doi: 10.1089/mdr.2015.0254. [PubMed: 26779992].
  • 41. Barker KF. Antibiotic resistance: a current perspective. Br J Clin Pharmacol. 1999;48(2):109-24. doi: 10.1046/j.1365-2125.1999.00997.x. [PubMed: 10417485]. [PubMed Central: PMC2014301].
  • 42. Moazzen Z, Eslami G, Hashemi A, Yousefi Nojookambari N. Efflux pump inhibitor carbonyl cyanide 3-chlorophenylhydrazone (CCCP) effect on the minimum inhibitory concentration of ciprofloxacin in acinetobacter baumannii strains. Arch Clin Infect Dis. 2018;13(2). doi: 10.5812/archcid.59644.
  • 43. Pagdepanichkit S, Tribuddharat C, Chuanchuen R. Distribution and expression of the Ade multidrug efflux systems in Acinetobacter baumannii clinical isolates. Can J Microbiol. 2016;62(9):794-801. doi: 10.1139/cjm-2015-0730. [PubMed: 27332787].
  • 44. Rajamohan G, Srinivasan VB, Gebreyes WA. Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides. J Antimicrob Chemother. 2010;65(2):228-32. doi: 10.1093/jac/dkp427. [PubMed: 20008046].
  • 45. Lin L, Ling BD, Li XZ. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Int J Antimicrob Agents. 2009;33(1):27-32. doi: 10.1016/j.ijantimicag.2008.06.027. [PubMed: 18790612].
  • 46. Zhu W, Wang H, Zhang JP. A comparison of adeB gene expression levels under conditions of induced resistance by different drugs in vitro in Acinetobacter baumannii. Exp Ther Med. 2017;13(5):2177-82. doi: 10.3892/etm.2017.4242. [PubMed: 28565825]. [PubMed Central: PMC5443273].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments